Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rheosorbilact vs Ringer's Lactate in Sepsis
NCT03764085Phase 4Completed
- Sponsor
- YURiA-PHARM
- Start
- Dec 2016
- Primary completion
- Dec 2019
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 5
01
Overview
A Phase 4 trial of rheosorbilact in sepsis, sponsored by YURiA-PHARM. Started Dec 2016; status: completed.
02
Drugs
rheosorbilact
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT03764085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03764085.